Efficacy, adverse events, and challenges of Dienogest in the management of symptomatic adenomyosis: A comparison with different hormonal treatments
Conclusions and Outlook
DNG represents an important therapeutic option to be included in the treatment algorithm for adenomyosis owing to sufficient pain relief, despite high rates of bleeding-related adverse events. Clinicians should consider an individual ’s potential risk factors for bleeding until high-quality evidence is available.
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research
More News: Bleeding | Databases & Libraries | Hormonal Therapy | Hormones | Infertility | Men | OBGYN | Pain | Pain Management | Reproduction Medicine | Study